| | | | | | | |
 | MODERNA, INC. | -5.07% | -9.34% | -40.94% | -62.39% | 1,019.33% | 61 810 |
| IQVIA HOLDINGS INC. | -0.41% | 0.39% | -15.07% | -6.03% | 52.90% | 44 878 |
 | LONZA GROUP AG | 2.39% | -1.61% | -24.63% | -23.73% | 64.80% | 43 629 |
| SEAGEN INC. | -0.93% | -2.77% | 9.45% | 6.58% | 113.14% | 31 500 |
| ALNYLAM PHARMACEUTICALS, INC. | 0.40% | -3.82% | 32.11% | 13.42% | 172.54% | 26 782 |
 | CELLTRION, INC. | -4.48% | -4.71% | 2.27% | -24.62% | 43.65% | 22 193 |
| ICON PUBLIC LIMITED COMPANY | -0.95% | -1.29% | -23.26% | -1.21% | 51.03% | 19 562 |
 | HANGZHOU TIGERMED CONSULTING CO., LTD. | -1.42% | -3.40% | -17.98% | -26.66% | 83.48% | 12 845 |
| PHARMARON BEIJING CO., LTD. | -2.64% | -5.74% | -22.98% | -39.78% | 163.46% | 12 361 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 0.15% | -2.86% | -41.51% | -47.03% | 68.58% | 11 192 |
| QIAGEN N.V. | -1.19% | -3.61% | -14.57% | -9.79% | 36.40% | 10 941 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | 0.00% | 0.61% | 7.40% | 27.32% | 287.77% | 10 582 |
| UNITED THERAPEUTICS CORPORATION | 0.38% | 0.06% | 2.95% | 9.39% | 171.90% | 10 088 |
 | GENSCRIPT BIOTECH CORPORATION | -0.90% | 1.47% | -20.43% | -21.12% | 57.40% | 7 466 |
| SYNEOS HEALTH, INC. | -0.87% | -2.79% | -34.37% | -23.09% | 31.98% | 6 978 |
| | | | | | | |
| | Promedio | -1.04% | -2.63% | -13.44% | -15.25% | 161.22% | |
| | Media ponderada por Capi. | -1.31% | -3.42% | -14.88% | -19.74% | 264.56% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Reporte
